메뉴 건너뛰기




Volumn 103, Issue 8, 2011, Pages 746-750

A nomogram predicting the probability of primary breast cancer survival at 2- and 5-years using pathological and biological tumor parameters

Author keywords

breast cancer; nomogram; overall survival; PAI 1; protease

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THYMIDINE KINASE;

EID: 79955685425     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21712     Document Type: Article
Times cited : (17)

References (29)
  • 1
    • 38849152398 scopus 로고    scopus 로고
    • Targeted therapies: A new generation of cancer treatments
    • Gerber DE:, Targeted therapies: A new generation of cancer treatments. Am Fam Physician 2008; 77: 311-319. (Pubitemid 351206593)
    • (2008) American Family Physician , vol.77 , Issue.3 , pp. 311-319
    • Gerber, D.E.1
  • 2
    • 35648993429 scopus 로고    scopus 로고
    • Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies
    • Viale G:, Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies. Breast 2007; 16: S55-S58.
    • (2007) Breast , vol.16
    • Viale, G.1
  • 5
    • 0019850184 scopus 로고
    • Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
    • Liotta LA, Goldfarb RH, Brundage R, et al.: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629-4636. (Pubitemid 12201384)
    • (1981) Cancer Research , vol.41 , Issue.11 , pp. 4629-4636
    • Liotta, L.A.1    Goldfarb, R.H.2    Brundage, R.3
  • 7
    • 15544384612 scopus 로고    scopus 로고
    • Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
    • Nomura T, Katunuma N:, Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9.
    • (2005) J Med Invest , vol.52 , pp. 1-9
    • Nomura, T.1    Katunuma, N.2
  • 8
    • 0034634751 scopus 로고    scopus 로고
    • Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas
    • Greco S, Marsigliante S, Leo G, et al.: Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas. Cancer Lett 2000; 160: 13-19.
    • (2000) Cancer Lett , vol.160 , pp. 13-19
    • Greco, S.1    Marsigliante, S.2    Leo, G.3
  • 10
    • 0034802806 scopus 로고    scopus 로고
    • Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and Cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy
    • Harbeck N, Alt U, Berger U, et al.: Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res 2001; 7: 2757-2764. (Pubitemid 32911381)
    • (2001) Clinical Cancer Research , vol.7 , Issue.9 , pp. 2757-2764
    • Harbeck, N.1    Alt, U.2    Berger, U.3    Kruger, A.4    Thomssen, C.5    Janicke, F.6    Hofler, H.7    Kates, R.E.8    Schmitt, M.9
  • 12
    • 0026779790 scopus 로고
    • Multiparametric prognostic evaluation of biological factors in primary breast cancer
    • Spyratos F, Martin PM, HacÃne K, et al.: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 1992; 84: 1266-1272.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1266-1272
    • Spyratos, F.1    Martin, P.M.2    Hacãne, K.3
  • 13
    • 0029865319 scopus 로고    scopus 로고
    • A computer program to assist in making breast cancer adjuvant therapy decisions
    • Ravdin PM:, A computer program to assist in making breast cancer adjuvant therapy decisions. Semin Oncol 1996; 23: 43-50. (Pubitemid 26105769)
    • (1996) Seminars in Oncology , vol.23 , Issue.1 SUPPL. 2 , pp. 43-50
    • Ravdin, P.M.1
  • 15
    • 50849143820 scopus 로고    scopus 로고
    • Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers
    • Shariat SF, Karam JA, Walz J, et al.: Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin Cancer Res 2008; 14: 3785-3791.
    • (2008) Clin Cancer Res , vol.14 , pp. 3785-3791
    • Shariat, S.F.1    Karam, J.A.2    Walz, J.3
  • 16
    • 33644663354 scopus 로고    scopus 로고
    • Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
    • Rouzier R, Pusztai L, Delaloge S, et al.: Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol 2005; 23: 8331-8339.
    • (2005) J Clin Oncol , vol.23 , pp. 8331-8339
    • Rouzier, R.1    Pusztai, L.2    Delaloge, S.3
  • 17
    • 67649959162 scopus 로고    scopus 로고
    • Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study
    • Coutant C, Olivier C, Lambaudie E, et al.: Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study. J Clin Oncol 2009; 27: 2800-2808.
    • (2009) J Clin Oncol , vol.27 , pp. 2800-2808
    • Coutant, C.1    Olivier, C.2    Lambaudie, E.3
  • 18
    • 67349278848 scopus 로고    scopus 로고
    • A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis
    • Houvenaeghel G, Nos C, Giard S, et al.: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009; 35: 690-695.
    • (2009) Eur J Surg Oncol , vol.35 , pp. 690-695
    • Houvenaeghel, G.1    Nos, C.2    Giard, S.3
  • 19
    • 0028838106 scopus 로고
    • Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy
    • Bonnier P, Romain S, Giacalone PL, et al.: Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995; 85: 11-17.
    • (1995) Obstet Gynecol , vol.85 , pp. 11-17
    • Bonnier, P.1    Romain, S.2    Giacalone, P.L.3
  • 20
  • 21
    • 0022531756 scopus 로고
    • Standardization of steroid receptor assays in human breast cancer. IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays
    • DOI 10.1016/0277-5379(86)90061-1
    • Koenders A, Thorpe SM:, Standardization of steroid receptor assays in human breast cancer - IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol 1986; 22: 945-952. (Pubitemid 16035146)
    • (1986) European Journal of Cancer and Clinical Oncology , vol.22 , Issue.8 , pp. 945-952
    • Koenders, A.1    Thorpe, S.M.2
  • 24
    • 0031031582 scopus 로고    scopus 로고
    • Tumor-related prognostic factors for breast cancer
    • Donegan WL:, Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997; 47: 28-51. (Pubitemid 27050848)
    • (1997) Ca-A Cancer Journal for Clinicians , vol.47 , Issue.1 , pp. 28-51
    • Donegan, W.L.1
  • 25
    • 0028905086 scopus 로고
    • Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer
    • Romain S, Christensen IJ, Chinot O, et al.: Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. Int J Cancer 1995; 61: 7-12.
    • (1995) Int J Cancer , vol.61 , pp. 7-12
    • Romain, S.1    Christensen, I.J.2    Chinot, O.3
  • 26
    • 67650382242 scopus 로고    scopus 로고
    • A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer
    • Colleoni M, Bagnardi V, Rotmensz N, et al.: A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. Ann Oncol 2009; 20: 1178-1184.
    • (2009) Ann Oncol , vol.20 , pp. 1178-1184
    • Colleoni, M.1    Bagnardi, V.2    Rotmensz, N.3
  • 27
    • 65349171945 scopus 로고    scopus 로고
    • A prediction model for breast cancer recurrence after adjuvant hormone therapy
    • Boracchi P, Coradini D, Antolini S, et al.: A prediction model for breast cancer recurrence after adjuvant hormone therapy. Int J Biol Markers 2008; 23: 199-206.
    • (2008) Int J Biol Markers , vol.23 , pp. 199-206
    • Boracchi, P.1    Coradini, D.2    Antolini, S.3
  • 29
    • 41149119907 scopus 로고    scopus 로고
    • External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy
    • Shariat SF, Walz J, Roehrborn CG, et al.: External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 2008; 26: 1526-1531.
    • (2008) J Clin Oncol , vol.26 , pp. 1526-1531
    • Shariat, S.F.1    Walz, J.2    Roehrborn, C.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.